Novartis To Make Sandoz A Stand-alone Firm
The business has received the final approval from the United States Food & Drug Administration for its abbreviated new drug application for Deferasirox tablets in the strength of 180 mg, Alembic Pharmaceuticals mentioned in a BSE filing. “Glenmark Pharmaceuticals Inc, USA has been granted final approval...
